Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma

by Hans-Georg Wirsching, Michael Weller, Stefan Balabanov, Patrick Roth
Published 2021-06-01

Dynamics of resistance development to imatinib under increasing selection pressure: a combination of mathematical models and in vitro data.

by Benjamin Werner, David Lutz, Tim H Brümmendorf, Arne Traulsen, Stefan Balabanov
Published 2011-01-01

Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions

by Benjamin Werner, Fabian Beier, Sebastian Hummel, Stefan Balabanov, Lisa Lassay, Thorsten Orlikowsky, David Dingli, Tim H Brümmendorf, Arne Traulsen
Published 2015-10-01

Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.

by Mascha Binder, Barbara Léchenne, Ramesh Ummanni, Christan Scharf, Stefan Balabanov, Maria Trusch, Hartmut Schlüter, Ingke Braren, Edzard Spillner, Martin Trepel
Published 2010-01-01

Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

by Michael Preukschas, Christian Hagel, Alexander Schulte, Kristoffer Weber, Katrin Lamszus, Henning Sievert, Nora Pällmann, Carsten Bokemeyer, Joachim Hauber, Melanie Braig, Stefan Balabanov
Published 2012-01-01

Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model

by Daniel Benten, Gunhild Keller, Alexander Quaas, Jorg Schrader, Artur Gontarewicz, Stefan Balabanov, Melanie Braig, Henning Wege, Jurgen Moll, Ansgar W. Lohse, Tim H. Brummendorf
Published 2009-09-01

Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors.

by Stefan Balabanov, Thomas Wilhelm, Simone Venz, Gunhild Keller, Christian Scharf, Heike Pospisil, Melanie Braig, Christine Barett, Carsten Bokemeyer, Reinhard Walther, Tim H Brümmendorf, Andreas Schuppert
Published 2013-01-01

Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

by Stefan Balabanov, Artur Gontarewicz, Gunhild Keller, Laura Raddrizzani, Melanie Braig, Roberta Bosotti, Jürgen Moll, Edgar Jost, Christine Barett, Imke Rohe, Carsten Bokemeyer, Tessa L Holyoake, Tim H Brümmendorf
Published 2011-04-01

Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines

by Felix Bremmer, Hanibal Bohnenberger, Stefan Küffer, Thomas Oellerich, Hubert Serve, Henning Urlaub, Arne Strauss, Yasmine Maatoug, Carl Ludwig Behnes, Christoph Oing, Heinz Joachim Radzun, Philipp Ströbel, Stefan Balabanov, Friedemann Honecker
Published 2019-01-01

Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.

by Ramesh Ummanni, Frederike Mundt, Heike Pospisil, Simone Venz, Christian Scharf, Christine Barett, Maria Fälth, Jens Köllermann, Reinhard Walther, Thorsten Schlomm, Guido Sauter, Carsten Bokemeyer, Holger Sültmann, A Schuppert, Tim H Brümmendorf, Stefan Balabanov
Published 2011-02-01

Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID-19

by Erik Hameister, Sebastian M. Stolz, Yvonne Fuhrer, Friedrich Thienemann, Dominik J. Schaer, Johannes Nemeth, Reto A. Schuepbach, Jeroen Goede, Sophie Reinhart, Adrian Schmidt, Abdullah Kahraman, Mathias Schmid, Holger Moch, Martin Zoche, Markus G. Manz, Stefan Balabanov, Steffen Boettcher
Published 2020-08-01

Overexpression of Gremlin-1 in patients with Loeys-Dietz syndrome: implications on pathophysiology and early disease detection.

by Jasmin Wellbrock, Sara Sheikhzadeh, Leticia Oliveira-Ferrer, Hauke Stamm, Mathias Hillebrand, Britta Keyser, Marianne Klokow, Gabi Vohwinkel, Veronika Bonk, Benjamin Otto, Thomas Streichert, Stefan Balabanov, Christian Hagel, Meike Rybczynski, Frank Bentzien, Carsten Bokemeyer, Yskert von Kodolitsch, Walter Fiedler
Published 2014-01-01

Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine

by Ioannis Chanias, Kristina Stojkov, Gregor Th. Stehle, Michael Daskalakis, Helena Simeunovic, Linet Muthoni Njue, Annatina S. Schnegg-Kaufmann, Naomi A. Porret, Ramanjaneyulu Allam, Tata Nageswara Rao, Rudolf Benz, Axel Ruefer, Adrian Schmidt, Marcel Adler, Alicia Rovo, Stefan Balabanov, Georg Stuessi, Ulrike Bacher, Nicolas Bonadies
Published 2021-06-01

A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation

by Henning Sievert, Nora Pällmann, Katharine K. Miller, Irm Hermans-Borgmeyer, Simone Venz, Ataman Sendoel, Michael Preukschas, Michaela Schweizer, Steffen Boettcher, P. Christoph Janiesch, Thomas Streichert, Reinhard Walther, Michael O. Hengartner, Markus G. Manz, Tim H. Brümmendorf, Carsten Bokemeyer, Melanie Braig, Joachim Hauber, Kent E. Duncan, Stefan Balabanov
Published 2014-08-01